Safeway vs Kenvue
Side-by-side comparison of AI visibility scores, market position, and capabilities
Western US supermarket chain with 900 stores under Albertsons Companies; Signature Select private label and Just for U loyalty program competing with Kroger after blocked merger.
About
Safeway is a major American supermarket chain operating approximately 900 stores primarily in the Western United States, Mid-Atlantic, and Alaska — known for its Signature Select private label products, Club Card loyalty program, and full-service deli, bakery, and pharmacy departments. Safeway is owned by Albertsons Companies (which acquired Safeway in 2015 for approximately $9.2 billion), making Safeway one of the Albertsons family of store banners alongside Vons, Jewel-Osco, Shaw's, Randalls, and others.\n\nSafeway's stores follow a traditional full-service supermarket model with departments including produce, meat, seafood, deli, bakery, floral, and pharmacy. The Signature Select and O Organics private label lines provide margin-accretive alternatives across grocery, meat, and dairy categories. The Just for U loyalty program (now integrated into the Albertsons apps) provides personalized digital coupons and rewards for Club Card members.\n\nIn 2025, Safeway operates within the broader Albertsons Companies portfolio (NYSE: ACI) following the failed merger with Kroger — the FTC successfully blocked the $25 billion Kroger-Albertsons merger in February 2024 after multiple years of regulatory review. Post-merger attempt, Albertsons Companies is refocusing on organic growth and operational efficiency for its banner portfolio. Safeway competes with Kroger, Trader Joe's, Costco, and regional grocers for Western US supermarket share. The 2025 strategy focuses on digital grocery pickup and delivery expansion, private label penetration, and store remodeling to compete with fresh-focused competitors like Whole Foods.
Skillman NJ consumer health (NYSE: KVUE) ~$15.5B FY2024 revenue; J&J spinoff May 2023, Tylenol/Band-Aid/Neutrogena/Listerine/Aveeno portfolio, talc litigation exposure competing with Haleon and P&G.
About
Kenvue Inc. is a Skillman, New Jersey-based consumer health company — publicly traded on the New York Stock Exchange (NYSE: KVUE) as an S&P 500 Consumer Staples component — marketing and selling over-the-counter medicines, skin health and beauty products, and essential health products through iconic consumer brands including Tylenol (pain and fever relief), Band-Aid (wound care), Neutrogena (skin care), Johnson's (baby care), Listerine (oral care), Aveeno (skincare), Motrin/Advil (ibuprofen pain relief), Zyrtec (allergy), Nicorette (smoking cessation), Neosporin (antibiotic ointment), and Benadryl through approximately 22,000 employees in 165 countries. Kenvue was separated from Johnson & Johnson through an IPO in May 2023 (the largest US IPO of 2023) and a tax-free distribution of J&J's remaining 89.6% stake to J&J shareholders in August 2023 — creating the world's largest pure-play consumer health company by market capitalization, with J&J retaining no ownership. In fiscal year 2024, Kenvue reported revenues of approximately $15.5 billion, with organic growth facing headwinds from lower cold/cough/flu season severity (Tylenol, Zyrtec, Benadryl volume sensitive to respiratory illness intensity), competitive pressure in skin health (Neutrogena competing with Korean beauty brands, Cerave, and pharmacy private label), and macroeconomic consumer trading down to lower-price alternatives in some markets. CEO Thibaut Mongon leads Kenvue's strategy of investing in the brand superiority of its household name portfolio while improving operational efficiency in the post-spinoff period (implementing Kenvue's own supply chain infrastructure, IT systems, and organizational structure previously shared with J&J).
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.